Narciso Almeida Vieira

Dr. Narciso Almeida Vieira

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2009 in Immunity & Ageing
Verified
Journal Article
Open access
PDF file
TGThaís Helena Gasparoto
Thaís Helena Gasparoto
Narciso Almeida VieiraNarciso Almeida Vieira
Narciso Almeida Vieira
VPVinícius Carvalho Carvalho Porto
Vinícius Carvalho Carvalho Porto
ACAna Paula Campanelli
Ana Paula Campanelli
VLVanessa Soares Lara
Vanessa Soares Lara
Ageing leads to a decline in the function of the immune system, increasing the body's susceptibility to infections through the impairment of T-cells, macrophages, neutrophils and dendritic cells Denture stomatitis is a primary oral disease affecting elderly denture wearers. The major etiologic factor involved in this pathology is the infection by Candida albicans, an opportunistic pathogen that causes local and disseminated diseases in immunosuppressed humans. Neutrophils play a critical role in the immune response against C. albicans and are continually present in the salivary fluid and in the blood. The aim of this study was to determine ageing-related changes in salivary and blood neutrophils and their potential implications in Candida-related denture stomatitis.

13 December 2010 in Journal of Oral Rehabilitation
Verified
Journal Article
Closed access
PDF file
TGT. H. Gasparoto
T. H. Gasparoto
Narciso Almeida VieiraNarciso Almeida Vieira
Narciso Almeida Vieira
VPV. C. Porto
V. C. Porto
ACA. P. Campanelli
A. P. Campanelli
VLVanessa Soares Lara
Vanessa Soares Lara

1 January 2021 in Journal of Applied Oral Science
Verified
Journal Article
Open access
PDF file
TGThaís Helena Gasparoto
Thaís Helena Gasparoto
TDThalita Marcato Dalboni
Thalita Marcato Dalboni
NANádia Ghinelli Amôr
Nádia Ghinelli Amôr
AAAneli Eiko Abe
Aneli Eiko Abe
GPGraziela Perri
Graziela Perri
ACAna Paula Campanelli
Ana Paula Campanelli
Objective Neutrophils are key effector cells of the innate immune system. They recognize antigens through membrane receptors, which are expressed during their maturation and activation. Neutrophils express FcγRII (CD32), FcγRIII (CD16), and FcγRI (CD64) after being activated by different factors such as cytokines and bacterial products. These receptors are involved with phagocytosis of IgG-opsonized microbes and enhance defense mechanisms. Based on that, our study seeks to compare the expression of FcγRII, FcγRIII, FcγRI, and CD11b on neutrophils from elderly and young subjects and their expression after in vitro activation with cytokines and LPS. Methodology Neutrophils were isolated from human peripheral blood and from mice bone marrow by density gradient. After isolation, FCγRs expression was immediately analyzed by flow cytometry or after in vitro stimulation. Results In freshly isolated cells, the percentage of FcγRIIIb+ and CD11b+ neutrophils were higher in samples from young individuals; FcγRIIIa expression was more prominent on aged neutrophils; FcγRIA expression was similar in all samples analyzed. Exposure to CXCL8 and LPS resulted in a higher percentage of FcγRIa+ neutrophils on elderly individuals’ samples but lower when compared with neutrophils from young donors. We observed that LPS caused an increase in FcγRIIa expression on aging human neutrophils. In contrast, FcγRIIIb expression in response to CXCL8 and LPS stimulation was not altered in the four groups. CD11b expression was lower in neutrophils from elderly individuals even in response to LPS and CXCL8. In mice, we observed differences only regarding CD11b expression, which was increased on aged neutrophils. LPS exposure caused an increase in all FcγRs. Conclusions Our results suggest that, in humans, the overall pattern of FcγR expression and integrin CD11b are altered during aging and immunosenescence might contribute to age-related infection.

1 September 2012 in Experimental Gerontology
Verified
Journal Article
Closed access
TGThaís Helena Gasparoto
Thaís Helena Gasparoto
COCarine Ervolino de Oliveira
Carine Ervolino de Oliveira
Narciso Almeida VieiraNarciso Almeida Vieira
Narciso Almeida Vieira
VPVinicius Carvalho Porto
Vinicius Carvalho Porto
CGCarlos Teodoro Gasparoto
Carlos Teodoro Gasparoto
VLVanessa Soares Lara
Vanessa Soares Lara

26 November 2011 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
TGT. H. Gasparoto
T. H. Gasparoto
COC. E. Oliveira
C. E. Oliveira
Narciso Almeida VieiraNarciso Almeida Vieira
Narciso Almeida Vieira
VPV. C. Porto
V. C. Porto
FCF. Q. Cunha
F. Q. Cunha
VLVanessa Soares Lara
Vanessa Soares Lara

1 September 2013 in Brazilian Journal of Microbiology
Verified
Journal Article
Open access
PDF file
Narciso Almeida VieiraNarciso Almeida Vieira
Narciso Almeida Vieira
HBHilton Coimbra Borgo
Hilton Coimbra Borgo
GDGisele da Silva Dalben
Gisele da Silva Dalben
MBMaria Irene Bachega
Maria Irene Bachega
PPPaulo Câmara Marques Pereira
Paulo Câmara Marques Pereira
This study isolated and quantified intestinal bacteria of children with cleft palate before and after palatoplasty. A prospective study was conducted from May 2007 to September 2008 on 18 children with cleft palate, aged one to four years, of both genders, attending a tertiary cleft center in Brazil for palatoplasty, to analyze the effect of surgical palate repair on the concentration of anaerobes Bacteroides sp, Bifidobacterium sp and microaerophiles Lactobacillus sp in feces of infants with cleft palate before and 24 hours after treatment with cefazolin for palatoplasty. There was significant reduction of Lactobacillus sp (p < 0.002), Bacteroides sp (p < 0.001) and Bifidobacterium sp (p = 0.021) after palatoplasty, revealing that surgery and utilization of cefazolin significantly influenced the fecal microbiota comparing collections before and after surgery. However, due to study limitations, it was not possible to conclude that other isolated factors, such as surgical stress, anesthetics and other medications used in palatoplasty might have a significant influence on the microbiota. Considering the important participation of the intestinal microbiota on both local and systemic metabolic and immunological activities of the host, professionals should be attentive to the possible influence of these changes in patients submitted to cleft repair.